Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:05:02.271Z.
Calculation as of: 2026-10-06T16:05:02.271Z.
Quote observation: 2026-10-06T15:56:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ca628ff6f55b6345e2cefca22780bd34dfabddebf8a5c62bf0c86d2d29f40561
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Phio Pharmaceuticals Corp.
Market Cap
$11.44M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.52M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.30M
Operating Cash Flow Yield
N/A
TTM Avg
42.53%
3Y Avg
42.53%
5Y Avg
42.53%
Market Cap
$11.62M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.82M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.93M
Operating Cash Flow Yield
N/A
TTM Avg
28.18%
3Y Avg
28.18%
5Y Avg
28.18%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | $11.44M | N/A | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.52M | N/A | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.54M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | N/A | 42.53% | 42.53% | 42.53% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.62M | N/A | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.82M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.08M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.36M | N/A | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | N/A | 28.18% | 28.18% | 28.18% |
| Caring Brands, Inc. (CABR)vs › | $10.68M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
